Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan versus fluid restriction for postoperative SIADH-related hyponatremia after transsphenoidal surgery
2012-004071-39Phase 4Active
- Sponsor
- Policlinico di Milano
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tolvaptan in hyponatraemia and syndrome of inappropriate antidiuresis (SIAD) (2 arms), sponsored by Policlinico di Milano. Primary endpoint: Normalization of serum sodium levels. Started Oct 2012; status: active.
02
Drugs
tolvaptan
03
Conditions
hyponatraemiasyndrome of inappropriate antidiuresis (SIAD)
Beyond the preview
Go deeper on 2012-004071-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004071-39.